The Intermountain Medical Center Heart Institute study is part of a larger study called faCTor-64, which is a landmark, randomized trial designed to determine if using CT scans to screen for heart disease in diabetic patients who don't have heart disease symptoms can help save lives.
As Intermountain researchers measured coronary artery plaque buildup in study participants, they discovered that a major controllable predictor of heart disease was BMI. Simply put: the greater the patient's BMI, the greater their risk for heart disease.
Researchers will present this study at the 2013 American Heart Association Scientific Sessions in Dallas, on Nov. 17 at 10 am, ET.
"Our study shows there's a strong linear relationship between BMI and plaque volume and composition," said J. Brent Muhlestein, MD, lead researcher and co-director of cardiovascular research at the Intermountain Medical Center Heart Institute in Murray, Utah. "So even being a little overweight is associated with more plaque, while being obese is associated with a lot of plaque."
Researchers say the findings are significant because heart disease causes about 75% of deaths in patients who have diabetes, but not everyone has obvious risk factors, such as smoking, high glucose levels, high cholesterol levels, or high blood pressure.
Patients with obvious risk factors can be treated, but for the patients who don't have obvious risk factors, their first indictor of heart disease is often in the form of a heart attack or stroke – or even death.
Current methods to measure plaque buildup are invasive and costly, and are not used to screen patients who don't display signs of heart disease. However, the coronary computed tomography angiography (CCTA) offers a new, and less invasive way to screen these patients for heart disease.
"It may be that in diabetic patients without any symptoms of heart disease, their BMI could be used to determine if they need a CT scan to screen for plaque buildup," said Muhlestein. "We could then develop a treatment plan for at-risk patients.
Findings from the study may also change the way diabetic patients are treated. Current diabetic management strategies include three options:
- Insulin-sensitizing medication to help the body's tissues become more sensitive to insulin and decrease glucose production
- Insulin-stimulating therapy to increase the pancreas' production of insulin
- Insulin injections
When patients are treated with insulin therapy and injections, they commonly experience weight gain. "When you provide more insulin, it's associated in almost every study with increased weight gain," said Dr. Muhlestein.
While weight gain does not necessarily predict heart disease in non-diabetics, the findings of this study shows that weight gain in diabetics can indicate the buildup of plaque. This is significant because the degree of weight gain can be reduced by using other types of diabetic treatments, such as insulin sensitizing medication.
"Based on the findings of this study, choosing insulin sensitizing therapy, as the primary management strategy in diabetic patients may be beneficial by reducing the tendency towards elevated BMI's, said Dr. Muhlestein.
Not only will the results of this study help researchers better understand which treatments will reduce weight gain, but they will also help researchers predict who will get heart disease – which will help physicians offer better long-term diabetic treatments to their patients.
"Our goal at the Intermountain Medical Center Heart Institute, is to learn how to predict who will get heart disease, so we can provide the best care possible and improve long-term outcomes – rather than waiting until a person has a heart attack or even dies," he said.
Other researchers involved in the study include: Alan C. Kwan, Heidi May, George Cater, Christopher T. Sibley, Boaz Rosen, Joao A.C. Lima, Donald Lappe, Jeffrey L. Anderson and David A. Bluemke.
Intermountain Heart Institute at Intermountain Medical Center is the most advanced heart program in the Intermountain West with highly specialized experts in all areas of heart care. Intermountain Medical Center is the flagship hospital for the Intermountain Healthcare system based in Salt Lake City.
Jess C. Gomez | EurekAlert!
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology